Back

Comorbidities as key therapeutic targets in heart failure.

30 August 2021 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Essentials in Heart Failure – 2: Therapeutic Targets Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Ewa Anita Jankowska

Wroclaw Medical University, Wroclaw (Poland)

2 More presentations in this session

Presentation thumbnail
Reduction in recurrent heart failure hospitalisations, cardiovascular and non-cardiovascular mortality: therapeutic targets in heart failure.
Professor O. Chioncel (Bucharest, RO)
Slides Video
Presentation thumbnail
Good quality of life and independence: therapeutic targets in heart failure.
Professor L. Hill (Londonderry, GB)
Slides Video

Access the full session

Session thumbnail
Essentials in Heart Failure – 2: Therapeutic Targets
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0
30 August 2025
thumbnail
Congress Session
Hottest trials and trial updates (2)
18 May 2025
thumbnail
Congress Session
Future outlooks into heart failure management in the cardio-renal-metabolic syndrome
19 May 2025
thumbnail
Congress Presentation
Comorbidities and risk factors: the (not so) other problems in heart failure with reduced ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources